Personalized Blood Test Improves MRD Detection in Patients with Breast Cancer

Tracking large numbers of individualized tumor mutations in cell-free DNA improved minimal residual disease detection in breast cancer patients, though the sensitivity is driven by the number of mutations available to track.

Source: CancerNetwork - March 13, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news